Synthesis and investigation of phthalocyanine-biotin conjugates by Vicente, M. Graca H. et al.
Louisiana State University 
LSU Digital Commons 
Faculty Publications Department of Chemistry 
1-1-2019 
Synthesis and investigation of phthalocyanine-biotin conjugates 
M. Graca H. Vicente 
Louisiana State Univ, Dept Chem, vicente@lsu.edu 
Elizabeth A. Okoth 
Louisiana State Univ, Dept Chem 
Zehua Zhou 
Louisiana State Univ, Dept Chem 
Benson Ongarora 
Louisiana State Univ, Dept Chem 
Follow this and additional works at: https://digitalcommons.lsu.edu/chemistry_pubs 
 Part of the Chemistry Commons 
Recommended Citation 
Vicente, M. Graca H.; Okoth, Elizabeth A.; Zhou, Zehua; and Ongarora, Benson, "Synthesis and 
investigation of phthalocyanine-biotin conjugates" (2019). Faculty Publications. 34. 
https://digitalcommons.lsu.edu/chemistry_pubs/34 
This Article is brought to you for free and open access by the Department of Chemistry at LSU Digital Commons. It 
has been accepted for inclusion in Faculty Publications by an authorized administrator of LSU Digital Commons. 
For more information, please contact gcoste1@lsu.edu. 
1st Reading
Journal of Porphyrins and Phthalocyanines
J. Porphyrins Phthalocyanines 2019; 23: 125–135
DOI: 10.1142/S1088424619500056
Published at http://www.worldscinet.com/jpp/
Copyright © 2019 World Scientific Publishing Company
INTRODUCTION
Phthalocyanines (Pcs) are efficient photosensitizers 
(ps) for the treatment of cancers by photodynamic therapy 
(PDT) [1]. PDT is a minimally invasive treatment that 
uses light, a ps and molecular oxygen to selective destroy 
malignant tissues via the generation of singlet oxygen 
(1O2) and reactive oxygen species (ROS). Photosens, 
a silicon(IV)Pc, and CGP55847, a zinc(II)Pc, are used 
clinically for the treatment of breast, gastrointestinal, 
and squamous cell carcinoma of the upper aerodigestive 
tract [2–4]. Pcs are an excellent choice as ps due to 
their strong absorbance in the near-infrared spectral 
region (> 670 nm) where light penetrates deeply through 
the skin, their high chemical and photo-stability, in 
addition to being excellent singlet oxygen generators 
[5–7]. However, Pcs generally have poor solubility in 
water and most organic solvents, which limits their 
purification and applications. Strategies used to address 
the poor solubility of Pcs include the introduction of 
bulky or water-solubilizing substituents, and the use of 
isomeric mixtures of compounds [4, 8–13]. Since the 
use of isomeric Pc mixtures can lead to reproducibility 
challenges, synthesis of isomerically pure compounds 
is a more desirable approach. In particular, isomerically 
pure Pcs bearing versatile functional groups can be 
used as templates to produce functionalized Pcs via, 
for example, esterification, substitution and acylation 
reactions [11–19]. The Pc templates can be conjugated 
to hydrophilic and cell-targeting moieties, yielding 
amphiphilic compounds with enhanced solubility, serum 
life, and specificity towards receptors overexpressed on 
cancer cells [11, 14, 20–22]. This strategy is particularly 
useful when the required precursors bearing targeting 
moieties are not readily available or are unstable under 
cyclization conditions [23–24]. The conjugation of 
tumor-cell-targeting moieties to Pc templates has been 
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ABSTRACT: An isothiocyanato-functionalized phthalocyanine (Pc) was synthesized in good yield 
from the corresponding amine-substituted Pc. This Pc reacted with ethanolamine, biotin hydrazine, and 
biotin diethylamine under mild conditions (room temperature in DMF or DMSO in the presence of TEA) 
to produce the corresponding thiourea products in 60–75% yields. All Pcs showed intense Q absorptions 
in DMF around 677 nm, emissions centered at 683 nm, and fluorescence quantum yields in the range 
0.18–0.27. The Pcs were phototoxic to human carcinoma HEp2 cells (IC50 ~ 7 at 1.5 J/cm
2) and localized 
in multiple organelles, including the lysosomes, Golgi and ER. One biotin-Pc conjugate was injected 
via tail vein into nude mice bearing HT-29 tumors and demonstrated selective localization in the tumor 
tissue.
KEYWORDS: phthalocyanine, isothiocyanate, biotin, photosensitizer, PDT.


















































































































Copyright © 2019 World Scientific Publishing Company J. Porphyrins Phthalocyanines 2019; 23: 126–135
126 E. A. OKOTH ET AL.
reported to improve the tumor specificity and uptake of 
Pc macrocycles [5, 9, 11, 20, 25–28]. However, some 
targeting agents, particularly those of high molecular 
weight, may trigger an immunogenic response [29]. 
Therefore, small tumor-targeting substituents such as low 
molecular weight PEG groups, peptides, and vitamins, 
including folic acid, riboflavin, vitamin B-12 and biotin, 
have been investigated as targeting moieties and have been 
shown to increase tumor selectivity and uptake into cancer 
cells [12, 25, 29–34]. Several cancer cell lines overexpress 
folate receptors, vitamin B-12 receptors and biotin 
receptors. Studies conducted on leukemia, ovarian, colon, 
mastocytoma, lung, renal, and breast cancer cell lines 
showed enhanced uptake of biotin conjugates compared 
to folate and vitamin B-12 conjugates [29]. Meerovich 
et al. reported that a biotin-containing Photosens showed 
higher photodynamic efficacy compared with the parent 
drug [35]. Photosens, however, is a mixture of isomers. 
Herein, we report the synthesis of an isomerically pure 
biotin-containing Pc, via reaction on a Pc template 
bearing an amine reactive isothiocyanato group. The 
conjugation of porphyrins, chlorins, bacteriochlorins 
and BODIPYs to various targeting molecules via an 
isothiocyanate functional group under mild conditions 
generally yields the targeted conjugates in short reaction 
times and high yields [36–41]. Duan et al. [11], Lopez-
Duarte et al. [17], and Hammer et al. [16], have reported 
the conjugation of isothiocyanate-functionalized Pcs to 
monoclonal antibodies, aluminosilicate Zeolite L and 
oligonucleotides, respectively. We report the synthesis of 
a regioisomerically pure isothiocyanate-functionalized 
Pc and its conjugation to biotin hydrazine and biotin 
diethylamine [42]. The spectroscopic and biological 
properties of the conjugates were evaluated and compared 
to those of the unconjugated Pc. 
RESULTS AND DISCUSSION
Synthesis
Scheme 1 shows the synthetic route to isothiocyanate-
functio nalized Pc 4. The precursor, 3-N-Boc-aminophenol 
phthalonitrile 1, was prepared according to our previously 
reported procedure [43]. Initial attempts to prepare the 
Boc-protected Pc 2 using various phthalonitrile ratios 
ranging from 1:3 to 1:9 led to formation of mixtures of 
Pc isomers. Such low ratios of phthalonitriles in cross 
condensation reactions are known to lead to mixtures 
of regioisomeric Pcs due to the interactions between 
the different phthalonitriles leading to the formation of 
adj- and opp-A2B2, A3B and AB3-type Pcs, in addition 
to the A4 and B4 Pcs in a single reaction vessel. These 
isomers are difficult to separate chromatographically 
due to their similar Rf values. However, using a large 
excess of one phthalonitrile (A) favors the formation of 
only A3B and A4 Pcs [18–19]. Therefore, the targeted 
A3B-type Pc 2 was synthesized using a 30-fold excess 
of unsubstituted phthalonitrile, and easily separated from 
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of the latter Pc. The condensation occurred in the 
presence of zinc(II) acetate and a catalytic amount of 
1,5-diazabicyclo[4.3.0]non-5-ene (DBN) as base in 
dimethylethanolamine(DMAE) at 140 °C for 1 h. Pc 2 was 
isolated in 12% yield after separation from the unsubstituted 
A4 Pc by filtration, followed by re-crystallization. Pc 2 
bearing a Boc-protected aminophenoxy a-substituent 
shows increased solubility compared with the unsubstituted 
A4 Pc and decreased tendency for aggregate formation.
Pc 2 was quantitatively deprotected using trifluoro-
acetic acid (TFA) in dichloromethane at 0 °C to give 
Pc 3. The amine group on Pc 3 was converted to the 
isothiocyanate functional group in Pc 4 using 1,1′- 
thicarbonyldi-2(1H)-pyridone (TDP) in anhydrous DMF, 
as shown in Scheme 1, using a procedure similar to that 
previously reported [36, 42]. Pc 4 was obtained in 90% 
yield. The isothiocyanate functional group is highly 
reactive toward amines, producing the corresponding 
thioamide addition products under mild conditions in 
high yields. 
Pc 4 reacted with ethanolamine in the presence 
of triethylamine (TEA) as base, at room temperature 
for 30 min, to produce hydroxyl Pc 5 in 66% yield, 
as shown in Scheme 2. Biotin ethylenediamine was 
synthesized by activation of the carboxylate group with 
EDCI and HOBt in DMSO, followed by reaction with 
N-Boc ethylenediamine in a 1:1 ratio, as previously 
reported [44]. Deprotection of the Boc group using 
TFA in dichloromethane for 2 h at 0 °C gave biotin 
ethylenediamine. Optimal reaction conditions for the 
conjugation of Pc 4 with biotin hydrazine and biotin 
ethylenediamine were found to be a 1:1 reaction ratio 
using TEA as the base, in DMSO over 2 h, to give Pc 6 
and Pc 7 in 60–75% yields, as shown in Scheme 2.
The structures of all Pcs were characterized by 1H- 
and 13C-NMR spectroscopy and by MALDI-TOF mass 
spectrometry (see Supporting information).
Spectroscopic properties
The spectroscopic properties for Pcs 4, 5, 6 and 7 in 
DMF are summarized in Table 1 and their absorption 
spectra are shown in Fig. 1. The absorption spectra of 
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Scheme 2. Reactions of Pc-NCS 4
Table 1. Spectroscopic properties for Pcs 4, 5, 6, and 7 in DMF at room 
temperature
Pc Absorption (lmax, nm) Emissiona (lmax, nm) Log e (nm) Ffb
4 677 682 5.00 0.26
5 678 684 4.95 0.27
6 674 682 4.85 0.18
7 678 684 4.80 0.19
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transition) between 674 and 678 nm and a Soret band 
between 300 and 400 nm. The spectra followed the Beer–
Lambert law at concentrations between 2 and 10 µL (see 
Supporting information). The fluorescence emissions 
appeared between 682 and 684 nm, and the fluorescence 
quantum yields ranged from 0.18–0.27. The biotin–Pc 
conjugates displayed lower fluorescence quantum yields 
than Pcs 4 and 5, maybe due to the higher flexibility 
of the conjugates which tend to increase non-radiative 
decay to the ground state.
Cellular studies
The cellular properties of Pcs 4, 5, 6 and 7, including 
their time-dependent cellular uptake, cytotoxicity and 
intracellular localization, were investigated in human 
carcinoma HEp2 cells, and the results are summarized 
in Table 2, Figs 2–6, and the Supporting information. For 
uptake studies, the HEp2 cells were incubated with 10 mM 
solutions of each Pc and the extent of uptake determined 
after 1, 2, 4, 8 and 24 h (Fig. 2). The isothiocyanate-Pc 
4 showed lower uptake at all time points investigated 
compared to the hydroxy-Pc 5 and biotin conjugates 6 
and 7. On the other hand, Pc 5 showed the highest uptake 
of all Pcs at all time points, and after 24 h accumulated 
within cells 8 times more than Pc 4. This might be due to 
its lower molecular weight and favorable amphiphilicity. 
The two biotin-containing Pcs 6 and 7 showed similar 
cellular uptake, and after 24 h were found within cells 4 
and 5 times more than Pc 4, respectively. 
The organelle-specific fluorescence probes BODIPY 
Ceramide (Golgi), Lyso-Sensor Green (lysosomes), Mito-
Tracker Green (Mitochondria), and ER Tracker Blue/
White (ER) (Invitrogen) were used in co-localization 
experiments. The red color indicates the Pc, the purple/
pink and orange/yellow colors indicate co-localization 
of the Pc and organelle probes in Figs 3–6. All Pcs 
localized in the ER, Golgi apparatus, and lysosomes 
(Table 3). In addition, to a small extent Pc 5 was also 
found in the mitochondria. The biotinylated Pcs 6 and 
7 showed similar localization in the lysosomes and the 
Golgi apparatus, with Pc 7 appearing to have enhanced 
localization in the ER compared with Pc 6. 
The dark toxicity and phototoxicity of the Pcs were 
investigated using Promega’s Cell Titer Blue viability 
assay. None of the Pcs was toxic in the dark up to 200 mM 
concentration. However, upon exposure to a low light 
dose (~1.5 J/cm2), all Pcs were phototoxic, particularly 
Pcs 5–7, with determined IC50 values (50% inhibition 
of cell proliferation based on dose-response curves) of 
70, 7, 9 and 6.5 mM for Pcs 4, 5, 6 and 7, respectively. 
Fig. 1. Absorption spectra of Pcs 4 (red), 5 (purple), 6 (pink), and 7 (blue) at 4 mM concentration in DMF at room temperature
Table 2. Cytotoxicity (CTB assay, light dose ~ 1.5 J/cm2) and comparative uptake 
for Pcs in HEp2 cells
Pc Dark toxicity IC50 (µM) Phototoxicity IC50 (µM) Uptake ratio at 24 h
a 
4 >200 70 1
5 >200 7 8
6 >200 9 4
7 >200 6.5 5
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Since all Pcs showed similar intracellular distributions, 
this result may be due to the lower cellular uptake of Pc 4 
into cells. The most phototoxic Pc was biotin conjugated 
Pc 7, probably due to its increased localization in the ER 
compared with all other Pcs. 
In vivo studies
The biotin-Pc conjugate 6 was selected based on the 
in vitro studies, for preliminary investigation in nude 
mice bearing human HT-29 colorectal tumors. In this 
experiment, Pc 6 was injected via tail vein into mice 
with subcutaneous tumors of approximately 5 mm in 
diameter. Post-injection, the mice were anesthetized 
and imaged using an excitation wavelength of 640 nm 
and an emission wavelength of 710 nm, at various time 
intervals for up to 120 h. As shown in Fig. 7a, systemic 
fluorescence of Pc 6 was observed in a representative 
mouse as early as 3 h post-injection, and selective 
localization was seen within tumors by 6 h after 
administration. Detection persisted through 48 h at the 
tumor site but declined after 72 and 120 h. However, 
non-specific background expression was also detected 
in the peritoneal region at each time point. After the 
final imaging scan, the mice were euthanized, and the 
organ and tumor tissues were harvested. Fluorescence 
analysis of tumor tissue from a representative mouse 
showed high levels of localization of Pc 6, as well as 
high levels in the kidneys, peritoneal fat, and uterus 
(Fig. 7b). Lower levels of Pc 6 were also detected in 
pancreas, liver, lungs, and intestines, while there was no 
detectable Pc 6 in either heart or spleen.
Fig. 2. Time-dependent uptake of Pcs 4 (red), 5 (purple), 6 
(pink), and 7 (blue) at 10 µM by human carcinoma HEp2 cells
Fig. 3. Subcellular localization of Pc 4 in HEp2 cells at 10 mM 
for 6 h. (a) Phase contrast (b) Overlay and fluorescence of 
Pc 4 (c) ER tracker Blue/White fluorescence (e) MitoTrack 
green fluorescence (g) BODIPY ceramide (i) LysoSensor 
green fluorescence (d, f, h, j) overlays of tracers with Pc 4 
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Fig. 4. Subcellular localization of Pc 5 in HEp2 cells at 10 µM 
for 6 h. (a) Phase contrast (b) Overlay and fluorescence of Pc 
5 (c) ER tracker Blue/White fluorescence (e) MitoTrack green 
fluorescence (g) BODIPY ceramide (i) LysoSensor green 
fluorescence (d, f, h, j) overlays of tracers with Pc 5 fluorescence. 
Scale bar: 10 µm
Fig. 5. Subcellular localization of Pc 6 in HEp2 cells at 10 mM 
for 6 h. (a) Phase contrast (b) Overlay and fluorescence of Pc 
6 (c) ER tracker Blue/White fluorescence (e) MitoTrack green 
fluorescence (g) BODIPY ceramide (i) LysoSensor green 
fluorescence (d, f, h, j) overlays of tracers with Pc 6 fluorescence. 
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EXPERIMENTAL 
Synthesis
General. All reagents and solvents were purchased 
from commercial sources and used directly without 
purification. Analytical thin-layer chromatography 
(TLC) was performed using plastic backed TLC plates 
254 (precoated, 200 µm) from Sorbent Technologies to 
monitor the reactions. Silica gel 60 (230 × 400 mesh) was 
used for column chromatography. NMR spectra were 
obtained on an AV-III-400-NanoBay Bruker spectrometer 
(400 MH for 1H, 100 MHz for 13C). Chemical shifts are 
reported in d (ppm) relative to DMF-d7 8.03 ppm (1H), 
163.15 ppm (13C); THF-d8 3.58 ppm (
1H), 67.57 ppm 
(13C); DMSO-d6 2.5 ppm (
1H), 39.51 ppm (13C). An 
a-Cyano-4-hydroxycinnamic acid matrix was used for 
MALDI-TOF mass spectra measurements on a Bruker 
ProFlex III spectrometer. Melting points were measured 
using a Barnstead Electrothermal Mel-Temp 1101D 
Capillary Melting Point Apparatus. Phthalonitrile 1 was 
synthesized as previously reported.43
Pc 2. A mixture of 3-(4-N-Boc-aminophenol) 
phthalo nitrile (0.03 g, 8.95 × 10-2 mmol), phthalonitrile 
(0.34 g, 2.68 mmol), and zinc(II) acetate (1.52 g, 
0.69 mmol) dissolved in DMAE (6.0 mL) was heated 
at 140 °C with two drops of DBN under argon for 
1 h. The solvent was removed under reduced pressure 
and the crude mixture was filtered using acetone. 
The product was further purified by silica gel column 
chromatography column to give Pc 2, a blue solid eluted 
using dichloromethane/methanol (95:5). Pc 2 was dried 
under vacuum for 2 days to give a blue solid in 12% 
yield. M.p.: 210 °C. 1H NMR (THF-d8, 400 MHz): 
7.8–7.75 (m, 2H, Ar-H), 7.63–7.61 (m, 2H, Ar-H), 7.19–
7.14 (m, 2H, Ar-H), 6.97–6.92 (m, 6H, Ar-H), 6.82–69 
(m, 6H, Ar-H), 2.06 (C (CH3)3). 
13C NMR (DMF-d7, 
100 MHz): 212.43 (C=O), 208.9, 168.8, 167.3, 155.0, 
153.8, 153.5, 153.4, 149.8, 138.9, 137.2, 136.6, 135.5, 
129.2, 122.6, 122.4, 120.6, 119.8, 118.6, 117.0, 79.3, 
55.7, 27.9 (C (CH3)3). MS (MALDI- TOF) m/z 783.230 
[M]+, calcd for C43H29N9O3Zn, 783.168.
Pc 3. The Boc group of Pc 2 was deprotected using 
TFA:DCM (1:1) at 0 °C for 4 h. The solvents were 
removed under reduced pressure and the resulting residue 
was dissolved in dichloromethane/methanol (9:1). A few 
drops of 2N NaOH were added to neutralize TFA and 
the precipitate removed by filtration. The product was 
dried under vacuum for 2 h to give Pc 3 as a blue solid 
in quantitative yield. M.p.: 250 °C. 1H NMR (DMF-d7, 
400 MHz): 9.5 (s, 2H, Ar-H), 8.3 (s, 2H, Ar-H), 7.9–
7.5 (M, 14H, Ar-H), 6.9–6.8 (M, 4H, Ar-H). 13C NMR 
(DMF-d7, 100 MHz): 153.4, 139.1, 138.7, 138.7, 130.0, 
128.8, 122.4, 122.2, 120.9, 117.1, 116.4, 115.2. (Ar-C, 
Fig. 6. Subcellular localization of Pc 7 in HEp2 cells at 10 mM 
for 6 h. (a) Phase contrast (b) Overlay and fluorescence of Pc 
7 (c) ER tracker Blue/White fluorescence (e) MitoTrack green 
fluorescence (g) BODIPY ceramide (i) LysoSensor green 
fluorescence (d, f, h, j) overlays of tracers with Pc 7 fluorescence. 
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CN). MS (MALDI- TOF) m/z [M + H]+ 684.172, calcd 
for C38H22N9OZn, 684.124. 
Pc 4. Pc 3 (50 mg, 0.73 mmol) was dissolved in 
100 mL anhydrous DMF. 1, 1′-Thiocarbonyldi-2,2′-
pyridone (16.9 mg, 0.73 mmol) dissolved in DMF was 
added to the Pc solution and the final mixture stirred 
at room temperature for 6 h. The solvent was removed 
under reduced pressure and the resulting residue was 
purified on silica gel preparative TLC plates using 
dichloromethane for elution, to give Pc 4 in 47.76 mg, 
90% yield. M.p.: 180 °C. 1H NMR (DMF-d7, 400 MHz): 
8.17 (s, 2H, Ar-H), 7.51–7.46 (m, 9H, Ar-H), 6.38 (d, J = 
2.8 Hz, 4H, Ar-H), 6.21 (t, J = 2.8 Hz, 4H, Ar-H). 13C 
NMR (DMF-d7, 100 MHz): 149.9, 149.6, 149.3, 141.0, 
136.0, 135.8, 135.5, 130.0, 123.8, 123.6, 123.3, 122.9, 
120.6, 104.9, 93.6. MS (MALDI- TOF) m/z 726.0803 
[M + H]+, calcd for C39H20N9OSZn, 726.062.
Pc 5. Pc 4 (5 mg, 6.896 µmol) was dissolved in 
50 µL DMF. Triethylamine (0.523 mg, 5.17 µmol) and 
ethanolamine (0.316 mg, 5.171 µmol) in 100 µL DMF 
were added to the Pc 4 solution and the final mixture 
was stirred for 0.5 h at room temperature. The solvent 
was removed under reduced pressure, and the crude 
product purified by column chromatography using 
dichloromethane/methanol (9:1) for elution to give Pc 5 
as a blue solid (2.7 mg, 66.41%). M.p.: 220 °C. 1H (DMF-
d7, 400 MHz): 8.3 (m, 4H, Ar-H), 7.5 (m, 6H, Ar-H), 6.3 
(s, 4H, Ar-H), 6.2 (s, 4H, Ar-H), 3.3 (m, 5H). 13C NMR 
(DMF-d7, 100 MHz): 161.3, 141.0, 135.7, 120.4, 104.8, 
70.4, 60.5, 42.1, 40.5. MS (MALDI- TOF) m/z 787.038 
[M + H]+, calcd for C41H27N10O2SZn, 787.133.
Pc 6. Pc 4 (5 mg, 6.90 µmol) was dissolved in 100 µL 
of DMSO. Biotin hydrazine (1.98 mg, 6.90 µmol) and 
triethylamine (28.85 µL, 207 mmol) in 50 µL DMSO 
were added to the Pc 4 solution. The final mixture was 
stirred for 2 h at room temperature. The crude product 
was precipitated out of solution by the addition of diethyl 
ether. The residue was re-dissolved in dichloromethane/
methanol (9:1) and washed once with water. The organic 
phase was dried over anhydrous Na2SO4 to give Pc 6 
as a blue compound (4.74 mg, 70%). M.p.: 190 °C. 1H 
NMR (DMSO-d6): 9.5–9.45 (6H, Ar-H), 8.3–8.3 (m, 6H, 
Ar-H), 7.8 (d, 1H, Ar-H), 7.66 (m, 2H, Ar-H), 7.5–7.4 
(m, 5H, Ar-H), 6.3 (m, 2H, Ar-H), 6.2–6.1 (m, 2H, Ar-H), 
4.1 (br, 2H), 3.6 (2H), 3.3 (3H), 3.1–3.0 (1H), 1.6 (1H), 
Table 3. Major (+++) and Minor (+) subcellular sites 
of localization in HEp2 Cells
Pc ER Golgi Mitochondria Lysosomes
4 ++ ++ - +++
5 ++ +++ + +++
6 + +++ - +++
7 +++ +++ - +++









Fig. 7. (a) Fluorescence images (excitation 640 nm and emission 710 nm) of a nude mouse bearing subcutaneous HT-29 tumor 
implants at 0, 3, 6, 24, 48, 72, and 120 h following i.v administration of Pc 6. The tumor position is circled. (b) Fluorescence images 
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1.3 (5H), 0.9 (1H). 13C NMR (DMSO-d6, 100 MHz): 
149.9, 149.6, 149.3, 147.2, 141.0, 138.8, 136.0, 135.6, 
135.7, 135.5, 130.0, 123.8, 123.6, 123.3, 122.8, 120.6, 
115.2, 111.0, 110.1, 104.9, 93.6, 90.6, 90.3, 55.0, 49.1, 
40.4, 20.0. MS (MALDI- TOF) m/z 1006.190 [M + Na]+, 
calcd for C49H37N13O3S2Zn, 1006.177.
Pc 7. Pc 4 (10 mg, 0.14 mmol) was dissolved in 100 mL 
of DMF. Biotin ethylenediamine (7.89 mg, 0.28 mmol) 
was dissolved in 200 mL DMSO and triethylamine 
(41.87 mg, 0.41 mmol) was added onto this before 
adding this mixture to the Pc 4 solution. The solvent 
was removed. The crude in dichloromethane/methanol 
9:1 was purified on silica gel TLC preparative plates to 
give title Pc 7 (16.74 mg, 60%). M.p.: 170 °C. 1H NMR 
(DMSO-d6): 9.3–9.1 (m, 5H, Ar-H), 8.2–8.1 (m, 7H, 
Ar-H), 7.6–7.5 (m, 3H, Ar-H), 7.2–7.0 (m, 1H, Ar-H), 
3.8–3.7 (m, 5H), 3.5 (m, 2H), 3 (m, 2H), 2.4 (m, 1H), 
2.3–2.1 (m, 4H), 1.8–1.5 (m, 7H), 1.5 (b, 2H), 1 (m, 1H) 
13C NMR (DMSO-d6, 100 MHz): 162.6, 162.3, 162.0, 
149.9, 149.6, 123.9, 123.6, 123.4, 55.0, 35.4, 35.2, 35.0, 
34.8, 34.6, 34.4, 34.2, 30.3, 30.1, 29.9, 29.7, 29.5, 29.3, 
29.1. MS (MALDI-TOF) m/z 1050.097 [M]+, calcd for 
C51H41N13O3S2ZnK, 1050.182.
Spectroscopic properties
All studies were performed in peptide-sequencing 
grade DMF solutions. All absorption spectra were 
measured on a UV-vis Perkin Elmer Lambda 35 spectro- 
photometer. All experiments were carried out within 
3 h of solution preparation at room temperature (23–
25 °C) using a 10 mm path length spectrophotometric 
cell. Emission spectra were recorded on a Fluorolog®-
HORIBA JOBINVYON (Model LFI-3751). The 
fluorescence quantum yields (Ff) were determined via a 
secondary standard method using ZnPc (Ff = 0.17) as the 
Ref. [45]. 
Cell studies
The HEp2 cells were obtained from ATCC and 
maintained in a 75 cm2 flask (Chemglass) with medium 
(DMEM:Advanced, 1:1) containing 10% FBS and 1% 
antibiotic (Life Technologies). The Pc solutions were 
prepared by dissolving each Pc in 100% DMSO at a 
concentration of 32 mM (stock solution).
Dark cytotoxicity. The HEp2 cells were placed in a 
Costar 96-well plate (15,000 cells/well). Each plate was 
treated with Pc concentrations of 200, 100, 50, 25, 12.5, 
and 0 mM for 0–24 h incubation at 37 °C. To end treatment, 
excess Pc was removed by washing cells with PBS and 
replaced with media containing 20% Cell Titer Blue 
(Promega). The cells were incubated for an additional 4 h 
at 37 °C, and measured fluorescently at 570/615 nm using 
a FluoStar Optima micro-plate reader. Dark toxicity is 
expressed in terms of percent survival of cells. 
Phototoxicity. The Pc concentrations of 100, 50, 
25, 12.5, 6.25, 3.125, and 0 mM were used for the 
phototoxicity experiments. HEp2 cells were placed in 
96 well plates as described above, and treated with the 
Pc solutions for 24 h at 37 °C. After this treatment the 
loading media was removed. The cells were washed 
with a PBS buffer, and then refilled with fresh media. 
The cells were exposed to a 600 W halogen lamp light 
source filtered with a water filter and a beam turning 
mirror (Newport) for 20 min. The total light dose was 
approximately 1.5 J/cm2. After being exposed to light, the 
cells were returned to the incubator for 24 h. After 24 h 
incubation, the medium was removed and replaced with 
media containing 20% Cell Titer Blue. The cells were 
incubated for an additional 4 h. The viable cells were 
measured fluorescently at 570/615 nm using a FluoStar 
Optima micro-plate reader. Phototoxicity is expressed in 
terms of percent survival of cells. 
Time-dependent cellular uptake. The HEp2 cells 
were plated in a 96-well plate as described above. The 
cells were treated by adding 100 mL of 10 mM Pc solution 
at different time periods of 0, 1, 2, 4, 8, and 24 h. The 
cells were washed with PBS, and solubilized by adding 
100 mL 0.25% Triton X-100 in PBS per well. The cells 
were quantified by CyQuant Cell Proliferation Assay 
(Life Technologies). The compound and cell number 
were determined using a FluoStar Optima microplate 
reader. Cellular uptake is expressed in terms of nM Pc 
concentration per cell. 
In vivo studies
For the in vivo studies, athymic nu/nu mice (Charles 
River Laboratories, Wilmington MA) were purchased 
at six weeks of age and quarantined for one week. 
Subsequently, the human colorectal adenocarcinoma 
HT-29 cell line (ATCC; Manassas, VA) was implanted 
subcutaneously in the lower right flank. Initially, HT-29 
cells were cultured in McCoy’s 5A medium containing 
10% fetal bovine serum (Atlanta Biologicals; Flowery 
Branch, GA) and incubated at 37 °C and 5% CO2 
under humidified conditions to approximately 75% 
confluence. The cells were then harvested with a 0.25% 
(w/v) trypsin -0.53 mM EDTA solution, concentrated 
via centrifugation, and resuspended in Dulbecco’s PBS 
before injection. Each of the mice was injected with 
5 × 106 cells in 0.1 mL PBS. Tumors were allowed to 
develop until approximately 5 mm in diameter, after 
which mice were subjected to lateral tail vein injection 
of the Pc conjugate resuspended at 2 mM in Dulbecco’s 
PBS containing 10% DMSO and 5% Kolliphor EL 
(Sigma-Aldrich, St. Louis, MO). After injection, the 
mice were observed for any acute adverse responses 
and then anesthetized using 3% isoflurane for imaging. 
Fluorescence imaging was performed at 0, 3, 6, 24, 48, 
72, and 120 h after injection using a Spectral AMI optical 
imaging system (Spectral Instruments Imaging; Tucson, 
AZ) set at an excitation 640 nm and emission 710 nm. 
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reviewed and approved by the Institutional Animal Care 
and Use Committee (IACUC) of LSU.
CONCLUSIONS
We describe the synthesis of an isomerically pure 
A3B-type Pc functionalized with an isothiocyanate group, 
Pc 4, in 11% overall yield. The strategy involves the 
condensation of a Boc-protected amino phthalonitrile 
with a large excess (30-fold) of phthalonitrile, followed 
by deprotection with TFA and reaction with TDP. The 
highly reactive isothiocyanate functional group readily 
reacts with primary amines under mild conditions and 
in high yields. Using this strategy, three new Pcs were 
prepared bearing ethanolamine, biotin hydrazine or biotin 
ethylenediamine, in 60–75% yields. These amphiphilic 
conjugates showed enhanced solubility and uptake into 
human carcinoma HEp2 cells. In DMF solutions the 
Pcs show absorption and emission spectra typical of Pc 
macrocycles, and fluorescence quantum yields in the 
range 0.18–0.27. All Pcs were non-toxic in the dark up 
to 200 mM concentrations, but displayed significant 
phototoxicity, with IC50 values in the order of 7 mM 
using 1.5 J/cm2 light dose. The biotin-Pc 6 was further 
investigated in a mouse model bearing a HT-29 tumor. 
This conjugate was found to selectively localize within 
tumors as soon as 6 h after i.v. administration via the tail 
vein. Our results demonstrate that the isomerically pure 
isothiocyanate-functionalized Pc 4 is an excellent template 
for the synthesis of tumor cell-targeted amphiphilic Pc 
analogs in good overall yields and under mild conditions.
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